The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.
Rajnish Mehrotra, MD, MS
Advertisement
Articles by Rajnish Mehrotra, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
3
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
4
Monoclonal Antibodies Had Varying Efficacy in Treating MG
5